472 related articles for article (PubMed ID: 29373632)
1. Neurotransmitter deficits from frontotemporal lobar degeneration.
Murley AG; Rowe JB
Brain; 2018 May; 141(5):1263-1285. PubMed ID: 29373632
[TBL] [Abstract][Full Text] [Related]
2. GABA and glutamate deficits from frontotemporal lobar degeneration are associated with disinhibition.
Murley AG; Rouse MA; Jones PS; Ye R; Hezemans FH; O'Callaghan C; Frangou P; Kourtzi Z; Rua C; Carpenter TA; Rodgers CT; Rowe JB
Brain; 2020 Dec; 143(11):3449-3462. PubMed ID: 33141154
[TBL] [Abstract][Full Text] [Related]
3. Redefining the multidimensional clinical phenotypes of frontotemporal lobar degeneration syndromes.
Murley AG; Coyle-Gilchrist I; Rouse MA; Jones PS; Li W; Wiggins J; Lansdall C; Rodríguez PV; Wilcox A; Tsvetanov KA; Patterson K; Lambon Ralph MA; Rowe JB
Brain; 2020 May; 143(5):1555-1571. PubMed ID: 32438414
[TBL] [Abstract][Full Text] [Related]
4. Apathy and impulsivity in frontotemporal lobar degeneration syndromes.
Lansdall CJ; Coyle-Gilchrist ITS; Jones PS; Vázquez Rodríguez P; Wilcox A; Wehmann E; Dick KM; Robbins TW; Rowe JB
Brain; 2017 Jun; 140(6):1792-1807. PubMed ID: 28486594
[TBL] [Abstract][Full Text] [Related]
5. The neurophysiological effect of NMDA-R antagonism of frontotemporal lobar degeneration is conditional on individual GABA concentration.
Perry A; Hughes LE; Adams N; Naessens M; Murley AG; Rouse MA; Street D; Jones PS; Cope TE; Kocagoncu E; Rowe JB
Transl Psychiatry; 2022 Aug; 12(1):348. PubMed ID: 36030249
[TBL] [Abstract][Full Text] [Related]
6. Frontotemporal lobar degeneration: epidemiology, pathology, diagnosis and management.
Seltman RE; Matthews BR
CNS Drugs; 2012 Oct; 26(10):841-70. PubMed ID: 22950490
[TBL] [Abstract][Full Text] [Related]
7. Proton magnetic resonance spectroscopy in frontotemporal lobar degeneration-related syndromes.
Murley AG; Tsvetanov KA; Rouse MA; Jones PS; Sværke K; Li W; Carpenter A; Rowe JB
Neurobiol Aging; 2022 Mar; 111():64-70. PubMed ID: 34971846
[TBL] [Abstract][Full Text] [Related]
8. Disease-modifying therapies for tauopathies: agents in the pipeline.
Panza F; Imbimbo BP; Lozupone M; Greco A; Seripa D; Logroscino G; Daniele A; Colosimo C
Expert Rev Neurother; 2019 May; 19(5):397-408. PubMed ID: 30973276
[TBL] [Abstract][Full Text] [Related]
9. Atypical parkinsonian syndromes: a general neurologist's perspective.
Deutschländer AB; Ross OA; Dickson DW; Wszolek ZK
Eur J Neurol; 2018 Jan; 25(1):41-58. PubMed ID: 28803444
[TBL] [Abstract][Full Text] [Related]
10. Metabolomic changes associated with frontotemporal lobar degeneration syndromes.
Murley AG; Jones PS; Coyle Gilchrist I; Bowns L; Wiggins J; Tsvetanov KA; Rowe JB
J Neurol; 2020 Aug; 267(8):2228-2238. PubMed ID: 32277260
[TBL] [Abstract][Full Text] [Related]
11. Neurochemical biomarkers in the diagnosis of frontotemporal lobar degeneration: an update.
Oeckl P; Steinacker P; Feneberg E; Otto M
J Neurochem; 2016 Aug; 138 Suppl 1():184-92. PubMed ID: 27186717
[TBL] [Abstract][Full Text] [Related]
12. GABAergic cortical network physiology in frontotemporal lobar degeneration.
Adams NE; Hughes LE; Rouse MA; Phillips HN; Shaw AD; Murley AG; Cope TE; Bevan-Jones WR; Passamonti L; Street D; Holland N; Nesbitt D; Friston K; Rowe JB
Brain; 2021 Aug; 144(7):2135-2145. PubMed ID: 33710299
[TBL] [Abstract][Full Text] [Related]
13. Motor neuron TDP-43 proteinopathy in progressive supranuclear palsy and corticobasal degeneration.
Riku Y; Iwasaki Y; Ishigaki S; Akagi A; Hasegawa M; Nishioka K; Li Y; Riku M; Ikeuchi T; Fujioka Y; Miyahara H; Sone J; Hattori N; Yoshida M; Katsuno M; Sobue G
Brain; 2022 Aug; 145(8):2769-2784. PubMed ID: 35274674
[TBL] [Abstract][Full Text] [Related]
14. Deficient neurotransmitter systems and synaptic function in frontotemporal lobar degeneration-Insights into disease mechanisms and current therapeutic approaches.
Huber N; Korhonen S; Hoffmann D; Leskelä S; Rostalski H; Remes AM; Honkakoski P; Solje E; Haapasalo A
Mol Psychiatry; 2022 Mar; 27(3):1300-1309. PubMed ID: 34799692
[TBL] [Abstract][Full Text] [Related]
15. [Frontotemporal lobar degeneration: a diagnostic challenge].
Remes AM
Duodecim; 2010; 126(18):2189-95. PubMed ID: 21072965
[TBL] [Abstract][Full Text] [Related]
16. The clinical diagnosis of early-onset dementias: diagnostic accuracy and clinicopathological relationships.
Snowden JS; Thompson JC; Stopford CL; Richardson AM; Gerhard A; Neary D; Mann DM
Brain; 2011 Sep; 134(Pt 9):2478-92. PubMed ID: 21840888
[TBL] [Abstract][Full Text] [Related]
17. [Neuropsychological profile of frontotemporal lobar degeneration].
Carmona-Abellán MM; Luquin MR; Lamet I; Pujol Giménez N; Esteve-Belloch P; Rivero M
An Sist Sanit Navar; 2015; 38(1):79-92. PubMed ID: 25963461
[TBL] [Abstract][Full Text] [Related]
18. Current concepts in the classification and diagnosis of frontotemporal lobar degenerations: a practical approach.
Rohan Z; Matej R
Arch Pathol Lab Med; 2014 Jan; 138(1):132-8. PubMed ID: 24377823
[TBL] [Abstract][Full Text] [Related]
19. Frontotemporal lobar degeneration: epidemiology, pathophysiology, diagnosis and management.
Rabinovici GD; Miller BL
CNS Drugs; 2010 May; 24(5):375-98. PubMed ID: 20369906
[TBL] [Abstract][Full Text] [Related]
20. Molecular and behavioural abnormalities in the FUS-tg mice mimic frontotemporal lobar degeneration: Effects of old and new anti-inflammatory therapies.
de Munter J; Babaevskaya D; Wolters EC; Pavlov D; Lysikova E; V Kalueff A; Gorlova A; Oplatchikova M; Pomytkin IA; Proshin A; Umriukhin A; Lesch KP; Strekalova T
J Cell Mol Med; 2020 Sep; 24(17):10251-10257. PubMed ID: 32667139
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
